Table 2 Demographic and clinical characteristics
Variables | variceal bleeding (n = 195) |
|---|---|
Age, y, mean ± SD | 60 ± 11 |
Sex, male/ female, n (%) | 117 (60.0) / 78 (40.0) |
Child-Pugh class, A/B/C, n (%) | 43 (22.1) / 116 (59.5) /36 (18.4) |
MELD score | 13.11(12.26,14.59) |
BCLC stage, A/B/C/D, n (%) | 24 (12.3) / 92 (47.2) /54 (27.7) / 25 (12.8) |
Maximum tumor size, cm, mean ± SD | 4.95 ± 1.78 |
Multifocal tumor, n (%) | 67 (34.4) |
Bilobar tumor involvement, n (%) | 59 (30.2) |
Extent of portal vein tumor thrombus Grade I/ Grade II/Grade III/Grade IV, n (%) | 31(15.9) /30 (15.4) / 24 (12.3) /14 (7.2) |
Prior curative resection or ablation, n (%) | 63 (32.5%) |
Size of EV ≥ 4 mm/Size of EV < 4 mm, n (%) | 73 (37.4) / 77(39.5) |
Prior overt hepatic encephalopathy, n (%) | 26 (13.3) |
Ascites, n (%) | 182 (93.3) |
ALT (IU/L) | 26.7 (15.3–41.8) |
AST (IU/L) | 31.9 (23.0-51.2) |
Prothrombin time, s | 12.8 (11.8–14.6) |
Serum albumin (g/l) | 34.2 (29.8–38.7) |
Total bilirubin (µmol/l) | 29.1 (19.6–41.7) |
Platelet count (×109/mm3) | 93.5 (69.8-110.2) |
HCCPHTIS | 3.0 (2.0–4.0) |